News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
Immutep holds successful meeting with FDA on Phase III design in NSCLC
Activeport Launches Groundbreaking Network Ecosystem Orchestration Platform for Enterprises
Little Green Pharma delivers robust quarter
Neuren receives Rare Paediatric Disease Designation from FDA
Memphasys Eyes Breakthrough with New Oxidative Stress Measurement for Animal Reproduction
Opthea welcomes retina leaders to its Medical Advisory Board
Neurotech's Phase II/III autism trial shows further benefits
Next Science enters into US$5m unsecured loan facility
Immutep receives regulatory clearance for Phase 1 IMP761 trial
Zelira secures leading patents for HOPE 1 and HOPE 2
ALL CONTRIBUTORS
Staff Writer
Articles:
29
Avg. Rating:
ALL CONTRIBUTORS
Staff Writer
Articles:
29
Avg. Rating:
